inducement awards

NBHC grants 13,867 performance share units to Vista Bank executives post-acquisition, with vesting tied to cumulative EPS and relative asset return metrics through April 2029.

EyePoint grants stock options to six new employees as clinical program advances toward Phase 3 topline data for wet AMD therapy.

Pacira BioSciences awarded stock options and RSUs to three new employees totaling 7,900 shares at $22.10 exercise price under its inducement plan.

Aardvark Therapeutics granted 152,338 stock options to six new hires with exercise prices of $13.48-$12.67, vesting over four years with a one-year cliff.